All 3 doses of orforglipron superior to placebo with respect to primary end point of change in HbA1c from baseline to week 40.

For adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is associated ...

In 1970, someone over the age of 65 hospitalized for a heart attack in the United States had about a 60% chance of leaving ...

American Diabetes Month - November 2022 – Every November, people can reach out to various healthcare organizations to learn more about how to prevent and manage diabetes. The Association of Diabetes ...

To address this, researchers tested a new strategy: combining semaglutide (the active ingredient in Ozempic and Wegovy) with an experimental drug called bimagrumab. Bimagrumab is a lab-made antibody ...

Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped ...

When you stop eating meat, you can experience short-term and long-term effects. Here's what happens to your body.

Children with diabetes who inhaled their mealtime doses of insulin did just as well as those who injected insulin under the ...

Diabetes mellitus, defined by elevated glycemic markers, is a major risk factor for cardiovascular disease (CVD), which is the most common cause of death among adults with diabetes mellitus, 1 ...

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

Heart disease is the leading cause of death around the world. However, overall heart disease death rates over the past five ...

Glucotrack announced the results from its completed first-in-human clinical study of its implantable continuous glucose monitor (CGM) at the American Diabetes Association’s ...